- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic sialorrhea
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 484KB)
Incobotulinumtoxina – November 2024
IncobotulinumtoxinA; Lyophilised powder for injection 100 units; Xeomin®
Last updated
30 May 2025